RESISTANT CANCER
Clinical trials for RESISTANT CANCER explained in plain language.
Never miss a new study
Get alerted when new RESISTANT CANCER trials appear
Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough breast cancer
Disease control Recruiting nowThis early-stage study tests a new treatment for triple-negative breast cancer that has come back or stopped responding to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goal is …
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 02:09 UTC
-
Engineered immune cells take on Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis study tests a new treatment for pancreatic cancer that has returned after standard therapy. The treatment uses a patient's own immune cells, modified to target a protein called B7-H3 on cancer cells, and includes a safety switch to control side effects. About 27 adults will …
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC